Literature DB >> 10675780

Utrophin may be a precursor of dystrophin during skeletal muscle development.

S Lin1, J M Burgunder.   

Abstract

Expression patterns of utrophin were investigated and compared to those of dystrophin and associated proteins in skeletal muscle of rat embryos from E12 to E21 by immunohistochemistry. Utrophin was readily detected from E12 on, earlier than full-length dystrophin on E14. A shorter dystrophin isoform was observed from E12 to E16. The level of utrophin reached a maximum on E16-17 and then declined while that of dystrophin increased after E17. A complementary distribution of these two molecules was observed on E18. Beta-dystroglycan appeared as early as utrophin. Sarcoglycans, appearing from E14 on, were anchored first by utrophin and then by dystrophin. These results elucidate the chronological order of expression of the dytrophin/utrophin protein complex and indicate that this protein complex is originally stabilized by utrophin. This study supports our hypothesis that utrophin might be a developmental precursor of dystrophin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10675780     DOI: 10.1016/s0165-3806(99)00165-0

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  14 in total

1.  Soluble miniagrin enhances contractile function of engineered skeletal muscle.

Authors:  Weining Bian; Nenad Bursac
Journal:  FASEB J       Date:  2011-11-10       Impact factor: 5.191

2.  Impacts of dystrophin and utrophin domains on actin structural dynamics: implications for therapeutic design.

Authors:  Ava Yun Lin; Ewa Prochniewicz; Davin M Henderson; Bin Li; James M Ervasti; David D Thomas
Journal:  J Mol Biol       Date:  2012-04-11       Impact factor: 5.469

3.  Utrophin is lacking at the neuromuscular junctions in the extraocular muscles of normal cat: artefact or true?

Authors:  Maziar Assadi; Markus Müntener
Journal:  Histochem Cell Biol       Date:  2005-02-24       Impact factor: 4.304

4.  Changes in mechanosensitive channel gating following mechanical stimulation in skeletal muscle myotubes from the mdx mouse.

Authors:  Alfredo Franco-Obregón; Jeffry B Lansman
Journal:  J Physiol       Date:  2002-03-01       Impact factor: 5.182

Review 5.  Molecular Therapies for Muscular Dystrophies.

Authors:  Ava Y Lin; Leo H Wang
Journal:  Curr Treat Options Neurol       Date:  2018-06-21       Impact factor: 3.598

Review 6.  Progress in gene therapy for Duchenne muscular dystrophy.

Authors:  P R Clemens; F J Duncan
Journal:  Curr Neurol Neurosci Rep       Date:  2001-01       Impact factor: 5.081

7.  Myogenic Akt signaling attenuates muscular degeneration, promotes myofiber regeneration and improves muscle function in dystrophin-deficient mdx mice.

Authors:  Michelle H Kim; Danielle I Kay; Renuka T Rudra; Bo Ming Chen; Nigel Hsu; Yasuhiro Izumiya; Leonel Martinez; Melissa J Spencer; Kenneth Walsh; Alan D Grinnell; Rachelle H Crosbie
Journal:  Hum Mol Genet       Date:  2011-01-18       Impact factor: 6.150

8.  Dystrophin and utrophin isoforms are expressed in glia, but not neurons, of the avian parasympathetic ciliary ganglion.

Authors:  Rachel Blitzblau; Elizabeth K Storer; Michele H Jacob
Journal:  Brain Res       Date:  2008-05-06       Impact factor: 3.252

Review 9.  Targeting IRES-dependent translation as a novel approach for treating Duchenne muscular dystrophy.

Authors:  Christine Péladeau; Bernard J Jasmin
Journal:  RNA Biol       Date:  2020-11-19       Impact factor: 4.652

10.  Stabilization of the cardiac sarcolemma by sarcospan rescues DMD-associated cardiomyopathy.

Authors:  Michelle S Parvatiyar; Alexandra J Brownstein; Rosemeire M Kanashiro-Takeuchi; Judd R Collado; Karissa M Dieseldorff Jones; Jay Gopal; Katherine G Hammond; Jamie L Marshall; Abel Ferrel; Aaron M Beedle; Jeffrey S Chamberlain; Jose Renato Pinto; Rachelle H Crosbie
Journal:  JCI Insight       Date:  2019-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.